EMEA partnership Reprogene is actively seeking highly qualified partners to expand service offerings and leverage the latest genomics technologies in the Europe, Middle East and Africa region, presenting a clear collaboration and channel sales opportunity.

Private clinical genetics As a privately owned clinical genetics facility with a decade of experience and international accreditations, Reprogene appeals to buyers seeking high-credibility genomic testing for reproductive, prenatal, oncology and wellness applications.

Broad test portfolio The company covers multiple major medical disciplines from reproductive and prenatal genomics to general health and fertility metrics, enabling upsell and cross-sell across adjacent genomic testing needs for existing clients.

R&D driven Ongoing research and development efforts have improved IVF success rates, signaling opportunities to position advanced diagnostic innovations and partner with clinics or labs aiming to enhance treatment outcomes.

Competitive credibility International accreditations and patented technologies provide strong differentiators for sales conversations with hospitals, fertility centers and managed care organizations seeking validated, reliable genomic testing partners.